A new case report describes the first documented case of renal medullary carcinoma (RMC) diagnosed during pregnancy: a 24-year-old woman presenting at 16 weeks gestation with a 6-cm right renal mass, retroperitoneal lymphadenopathy, and lung metastases, with pathology confirming SMARCB1-deficient renal cell carcinoma unclassified with medullary phenotype (RCCU-MP). A pregnancy-safe chemotherapy regimen of doxorubicin plus cyclophosphamide followed by weekly paclitaxel — approaches established for other cancers in pregnancy — produced substantial tumor shrinkage and symptom relief, enabling safe preterm delivery of a healthy baby at 33 weeks, after which the patient received further combination chemotherapy and definitive radiation therapy and remained alive at 2 years post-diagnosis, exceeding the median survival for RCCU-MP. This case demonstrates that aggressive, multidisciplinary treatment can achieve favorable outcomes for both mother and fetus when RMC is diagnosed during pregnancy.